Exciting news for the healthcare industry as Medal, a company specializing in developing real-world evidence from clinical data, announces a successful funding round to the tune of $13,000,000. This funding will propel Medal's mission to provide reliable and consistent solutions for leveraging clinical data. By enabling the healthcare sector to harness real-world evidence effectively, Medal aims to revolutionize how the industry leverages data for improved patient outcomes and smarter decision-making. To learn more about Medal and their innovative approach, visit Medal.com and CioxRWD.com today. For any business inquiries or career opportunities, reach out to Info@medal.com and hr@Medal.com respectively. This substantial funding round signifies a significant step forward for Medal in their journey to transform healthcare data analytics.
Medal Secures $13 Million in Funding to Drive Real-World Evidence Solutions!
Recently funded 路 $13.0MInformation Technology & Services
Get the full Medal company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Aisot Technologies
Aisot Technologies is a Zurich-based AI company pioneering advanced, AI-driven investment solutions. Spun out of ETH Zurich in 2021, aisot leverages machine learning, large language models (LLMs), and quantitative methods to deliver precise, real-time investment insights. Its AI Insights Platform empowers asset managers, funds, family offices, and treasuries to anticipate market trends, optimize strategies, and mitigate risk. Recognized across Europe and the U.S., aisot partners with leading financial institutions to redefine quantitative investment management.
$2.5M Seed
today
Dognosis
Dognosis is a deep-tech startup in Bangalore decoding canine cognition to reveal the hidden world of scent. Our vision is a world where we have cracked the olfactory code of disease, making detecting disease as easy as breathing. Our mission is to save lives by detecting disease early and advance humanity towards truly proactive and preventative medicine. Our work revolves around increasing the bandwidth of human-canine collaboration, allowing us to catch the scent of disease at scale. Our first goal is to solve for early cancer detection by pioneering a multi-cancer breath-based test - BreathEasy - that will be ultra-affordable, highly accurate, and super accessible. We're always on the lookout for passionate and ambitious people to work with us. Feel free to say hi to woof@dognosis.tech
